Загрузка...

Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

OBJECTIVE: Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation. Although fingolimod-associated lymphopenia is a well-known phenomenon, the exact cause...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Kaufmann, Maxi, Haase, Rocco, Proschmann, Undine, Ziemssen, Tjalf, Akgün, Katja
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2018
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256977/
https://ncbi.nlm.nih.gov/pubmed/30524432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02669
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!